Medicine and Dentistry
Patient
100%
Chemoradiotherapy
54%
Levetiracetam
54%
Melanocytosis
54%
Nodular Melanoma
54%
Sodium Valproate
54%
Glioblastoma
54%
Toxicity
54%
Retrospective Cohort Study
54%
Inpatient
54%
Case Report
54%
Meningitis
36%
Magnetic Resonance Imaging
36%
Anticonvulsant Therapy
32%
Drug Therapy
32%
Side Effect
32%
Temozolomide
30%
Malignant Transformation
27%
Neoplasm
27%
Thrombocyte
21%
Hemoglobin
21%
Anticonvulsant
21%
Neutrophil
21%
Lymphocyte
21%
Granulocyte
21%
Brain
18%
Conus medullaris
18%
Stereotactic Radiotherapy
18%
Cytarabine
18%
Neurologic Examination
18%
Immunotherapy
18%
Diagnosis
18%
Therapeutic Procedure
18%
Deterioration
10%
Symptomatic Epilepsy
10%
Brain Tumor
10%
Blood Cell
10%
Epileptic Seizure
10%
Cell Count
10%
Mixed Model
10%
Brainstem
9%
Male
9%
Melanosis
9%
Diplopia
9%
Micturition
9%
Pigmented Lesion
9%
Melanocytic Tumor
9%
Radiculopathy
9%
Ophthalmoparesis
9%
Cytotoxic T Lymphocyte Antigen 4 Antibody
9%
Pharmacology, Toxicology and Pharmaceutical Science
Levetiracetam
54%
Sodium Valproate
54%
Glioblastoma
54%
Toxicity
54%
Cohort Study
54%
Chemotherapy
54%
Side Effect
32%
Temozolomide
21%
Hemoglobin
21%
Anticonvulsive Agent
21%
Deterioration
21%
Seizure
10%
Symptomatic Epilepsy
10%
Brain Tumor
10%
Pharmaceutical Therapy
10%
Neuroscience
Chemotherapy
54%
Levetiracetam
54%
Valproic Acid
54%
Glioblastoma Multiforme
54%
Temozolomide
21%
Neutrophil Granulocyte
21%
Thrombocyte
21%
Seizure
21%
Anticonvulsant
21%
Hemoglobins
21%
Brain Tumor
10%